BlackRock Fund Advisors’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

BlackRock Fund Advisors’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,778	Closed	-$1K	–	4371
2016 Q2	$1K	Sell	2,778 -36,973	-93%	-$59.4K	﹤0.01%	4335
2016 Q1	$107K	Sell	39,751 -3,178	-7%	-$8.92K	﹤0.01%	3651
2015 Q4	$133K	Buy	42,929 +1,578	+4%	+$7.11K	﹤0.01%	3664
2015 Q3	$183K	Sell	41,351 -1,092	-3%	-$6.42K	﹤0.01%	3501
2015 Q2	$242K	Buy	+42,443	New	+$290K	﹤0.01%	3452

Other funds holding EPRS

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BlackRock Fund Advisors's EPRS Position: Q3 2016 in Review

BlackRock Fund Advisors sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 2,778 shares — an estimated $1K sold.

BlackRock Fund Advisors first reported a position in EPRS in Q2 2015 and held it in 5 quarters. The position peaked at $242K in Q2 2015. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

BlackRock Fund Advisors reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
BlackRock Fund Advisors sold 2,778 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016, an estimated $1K.
BlackRock Fund Advisors first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q2 2015 and held it in 5 quarters.
BlackRock Fund Advisors's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $242K in Q2 2015.
3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on BlackRock Fund Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.